Scarica l'app Stockscreener
4.73
2.27%
-0.11
Dopo l'orario di chiusura:
4.55
-0.18
-3.81%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.84
Aprire:
$4.85
Volume 24 ore:
806.06K
Relative Volume:
0.73
Capitalizzazione di mercato:
$906.73M
Reddito:
$12.99M
Utile/perdita netta:
$-74.39M
Rapporto P/E:
-10.75
EPS:
-0.44
Flusso di cassa netto:
$-78.92M
1 W Prestazione:
+8.49%
1M Prestazione:
+4.19%
6M Prestazione:
+33.24%
1 anno Prestazione:
+23.02%
Intervallo 1D:
$4.71
$4.905
Intervallo di 1 settimana:
$4.30
$4.945
Portata 52W:
$2.705
$5.10
Arbutus Biopharma Corp Stock (ABUS) Company Profile
Nome
Arbutus Biopharma Corp
Settore
Industria
Telefono
604-419-3200
Indirizzo
701 VETERANS CIRCLE, WARMINSTER, PA
Confronta ABUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.73 | 927.82M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-02-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-25 | Iniziato | Jefferies | Hold |
| 2020-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-27 | Ripresa | JMP Securities | Mkt Outperform |
| 2020-07-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-03-06 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | Iniziato | Robert W. Baird | Outperform |
| 2020-02-05 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | Reiterato | B. Riley FBR | Buy |
| 2019-10-04 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2018-10-12 | Reiterato | Chardan Capital Markets | Buy |
| 2018-07-06 | Downgrade | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | Ripresa | Chardan Capital Markets | Buy |
| 2018-03-19 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | Reiterato | Wedbush | Outperform |
| 2016-12-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
Mostra tutto
Arbutus Biopharma Corp Borsa (ABUS) Ultime notizie
Why Arbutus Biopharma Corporation (I9DN) stock stays undervalued - newser.com
Will Arbutus Biopharma Corporation stock recover faster than marketJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com
Quantitative breakdown of Arbutus Biopharma Corporation recent moveQuarterly Portfolio Summary & Long-Term Safe Investment Plans - newser.com
Signal strength of Arbutus Biopharma Corporation stock in tech scannersWeekly Trend Recap & Technical Analysis for Trade Confirmation - newser.com
Can Arbutus Biopharma Corporation stock deliver surprise earnings beat2025 Trading Recap & Reliable Breakout Forecasts - newser.com
Arbutus Biopharma Corporation (ABUS) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Can Arbutus Biopharma Corporation stock continue upward trend2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Custom strategy builders for tracking Arbutus Biopharma CorporationGDP Growth & Daily Entry Point Trade Alerts - newser.com
Arbutus Biopharma (ABUS) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Can Arbutus Biopharma Corporation stock sustain revenue growthForecast Cut & Advanced Technical Analysis Signals - newser.com
Intraday pattern recognizer results for Arbutus Biopharma Corporation2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Arbutus Biopharma Corporation stock trend outlook and recovery pathPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Is this a good reentry point in Arbutus Biopharma Corporation2025 Institutional Moves & Fast Gaining Stock Strategy Reports - newser.com
Can Arbutus Biopharma Corporation stock resist market sell offsShort Setup & Reliable Breakout Stock Forecasts - Fundação Cultural do Pará
Aug Mood: Can Arbutus Biopharma Corporation stock continue upward trendRate Cut & Weekly Watchlist of Top Performers - fcp.pa.gov.br
Is it time to cut losses on Arbutus Biopharma CorporationJuly 2025 Movers & Daily Risk Controlled Trade Plans - newser.com
What technical signals suggest for Arbutus Biopharma Corporation stockEarnings Growth Report & High Accuracy Buy Signal Tips - fcp.pa.gov.br
Will Arbutus Biopharma Corporation (I9DN) stock see insider accumulationShort Setup & Accurate Entry/Exit Alerts - newser.com
Arbutus Biopharma’s (ABUS) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World
How Arbutus Biopharma Corporation (I9DN) stock trades under stagflationMarket Activity Summary & Free High Return Stock Watch Alerts - newser.com
What to do if you’re stuck in Arbutus Biopharma CorporationQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
Published on: 2025-10-26 22:31:52 - newser.com
Can Arbutus Biopharma Corporation stock attract ESG capital inflowsWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Arbutus Biopharma to Present New Data on Imdusiran and AB-101 at AASLD 2025 - MSN
Arbutus Biopharma Corp Azioni (ABUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):